Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE: V global payments network at $35.93B FY2024 revenue with 4.48B cards and $15T+ annual volume; 52.2% credit card market share with 233.8B transactions competing with Mastercard and A2A payment rails.
Visa Inc. is a San Francisco-based global payments technology company — listed on NYSE (NYSE: V) — operating the world's largest electronic payment network connecting 4.48 billion active cards, 150+ million merchant locations, and 15,000+ financial institution partners across 200+ countries and territories, facilitating $15+ trillion in payment volume annually. Visa generated $35.93 billion in net revenues in fiscal year 2024 (+10% year-over-year) with $19.7 billion in net income (55% net margin) from payment volume fees, data processing fees, and international transaction fees — without issuing a single credit card or carrying any credit risk. Founded in 1958 as the BankAmericard program and reorganized as Visa Inc. through a 2008 IPO, Visa is the infrastructure provider that enables the global credit and debit card ecosystem to function: every Visa card issued by Citibank, Chase, HDFC, or 15,000 other banks worldwide runs on Visa's authorization, clearing, and settlement network.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.